Background
Extra-Corporeal Membrane Oxygenation (ECMO) is a life-saving intervention for severe respiratory and cardiac diseases. However, 50% of survivors have abnormal neurologic exams. Current ECMO management is guided by systemic metrics, which may poorly predict cerebral perfusion. Continuous optical monitoring of cerebral hemodynamics during ECMO holds potential to detect risk factors of brain injury such as impaired cerebrovascular autoregulation (
CA
).
Methods
We conducted daily measurements of microvascular cerebral blood flow (
CBF
), oxygen saturation, and total hemoglobin concentration using diffuse correlation spectroscopy (DCS) and frequency-domain diffuse optical spectroscopy in 9 neonates. We characterize
CA
utilizing the correlation coefficient (
DCSx
) between
CBF
and mean arterial blood pressure (
MAP
) during ECMO pump flow changes.
Results
Average
MAP
and pump flow levels were weakly correlated with
CBF
and were not correlated with cerebral oxygen saturation.
CA
integrity varied between individuals and with time. Systemic measurements of
MAP
, pulse pressure, and left cardiac dysfunction were not predictive of impaired
CA
.
Conclusions
Our pilot results suggest that systemic measures alone cannot distinguish impaired
CA
from intact
CA
during ECMO. Furthermore, optical neuromonitoring could help determine patient-specific ECMO pump flows for optimal
CA
integrity, thereby reducing risk of secondary brain injury.